June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
IRF-8 Antagonizes Th17 and Tc17 Expansion and Restrains Th17 Inflammatory Responses During Autoimmune Uveitis
Author Affiliations & Notes
  • Sung-Hye Kim
    Laboratory of Immunology, NEI, Bethesda, MD
  • Chengrong Yu
    Laboratory of Immunology, NEI, Bethesda, MD
  • Bernadette Marrero
    Laboratory of Immunology, NEI, Bethesda, MD
  • Charles E. Egwuagu
    Laboratory of Immunology, NEI, Bethesda, MD
  • Footnotes
    Commercial Relationships Sung-Hye Kim, None; Chengrong Yu, None; Bernadette Marrero, None; Charles E. Egwuagu, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2535. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sung-Hye Kim, Chengrong Yu, Bernadette Marrero, Charles E. Egwuagu; IRF-8 Antagonizes Th17 and Tc17 Expansion and Restrains Th17 Inflammatory Responses During Autoimmune Uveitis. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2535.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Interferon Regulatory Factor (IRF) factors play important roles in host immunity. Currently, there are nine known IRFs. They are expressed ubiquitously, except IRF-8 whose expression is restricted to myeloid and B cells. However, when naïve T cells are stimulated with Ag, IRF-8 is copiously induced. Nonetheless, the significance of IRF-8 expression in activated T cells is unknown. In this study, we have investigated the function of IRF-8 in activated T cells of mutant mice withtargeted deletion of IRF-8 in CD4 and CD8 T cells (CD4/CD8KO).

Methods: We generated the CD4/CD8 KO mouse strain by breeding IRF-8 floxed mice (IRF-8fl/fl) mice (kind gift from Herbert Morse, NIH) with CD4/Cre mice. Deletion of IRF-8 was confirmed by western blot analysis of TCR-activated CD4+and CD8+ T cells from the CD4/CD8KO mice. Homozygous CD4/CD8 IRF-8KO mouse strain was established by several cycles of brother-sister mating. Effector functions ofCD4/CD8KO T cells were characterized by Thymidine-incorporation assay, CFSE labeling, RT-PCR, western blot analysis, intracellular cytokine staining assays. In vivo functions of IRF-8 were investigated by active immunization of WT or CD4/CD8KO mice with IRBP/CFA and we examined whether IRF-8 in T cells can influence the development or susceptibility to experimental autoimmune uveitis (EAU). We monitored the progression and severity of EAU by fundoscopy and histology.

Results: Compared to WT, CD4/CD8KO mice developed a more severe EAU, which is characterized by massive infiltration of cells into the retina, papilledema, focal retinitis, retinal vasculitis and multifocal-choroiditis. Compared to WT, CD4/CD8KO T cells produced three-folds and four-folds higher levels of IL-17-expressing Th17 and Tc17 cells, respectively, which may have contributed to the severe ocular pathology. CD4+ and CD8+ T cells from CD4/CD8KO exhibited higher proliferative capacity and were more susceptible to apoptosis.

Conclusions: Our data suggest that IRF-8 expression in activated T cells antagonizes Th17 and Tc17 expansion and restrains excessive Th17 inflammatory responses that occur during autoimmune disease. On the other hand, enhanced apoptosis manifested by CD4/CD8KO T cells suggests that IRF-8 may enhance productive immune responses against pathogens (e.g. S.aureus, S. Pneumoniae, Candida albicans and other fungi) by conferring stability to the Th17 and Tc17 T cell subsets.

Keywords: 555 immunomodulation/immunoregulation • 746 uveitis-clinical/animal model • 533 gene/expression  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.